Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V E POLLAK

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
The Journal of Laboratory and Clinical Medicine|November 1, 1986
Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpuraP Glas-Greenwalt, J M Hall, T W Panke, et al.
Thrombosis Research|September 15, 1982
Deficiency of a plasma factor stimulating vascular prostacyclin generation in patients with lupus nephritis and glomerular thrombi and its correction by ancrod: in-vivo and in-vitro observationsK S Kant, A K Dosekun, K G Chandran, et al.
American Journal of Nephrology|January 1, 1986
Effect of first and subsequent use of hemodialyzers on patient well-being. Analysis of the incidence of symptoms and events and description of a syndrome associated with new dialyzer useM D Robson, R Charoenpanich, K S Kant, et al.
Prostaglandins|August 1, 1986
Beneficial effects of polyunsaturated fatty acids in partially nephrectomized ratsU O Barcelli, J Miyata, Y Ito, et al.
The Quarterly Journal of Medicine|November 1, 1988
Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effectsS Kim, N K Wadhwa, K S Kant, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1985
Results of treatment in patients with end-stage renal disease: a multivariate analysis of risk factors and survival in 341 successive patientsG Garcia-Garcia, J A Deddens, R D'Achiardi-Rey, et al.
American Journal of Nephrology|January 1, 1982
Wegener's granulomatosis: prolonged patient survival after pneumonectomy and renal transplantationP K Chandran, M R First, M A Weiss, et al.
Annals of Emergency Medicine|November 1, 1988
Use of ancrod in acute or progressing ischemic cerebral infarctionC P Olinger, T G Brott, W G Barsan, et al.
Archives of Internal Medicine|January 1, 1984
Ancrod in systemic lupus erythematosus with thrombosis. Clinical and fibrinolysis effectsA K Dosekun, V E Pollak, P Glas-Greenwalt, et al.
Clinical Nephrology|August 1, 1982
Successful treatment by defibrination with ancrod in a patient with hyperacute renal allograft failure and a deficiency of plasma prostacyclin stimulating factorA K Dosekun, M R First, P K Chandran, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
The Journal of Laboratory and Clinical Medicine|November 1, 1986
Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpuraP Glas-Greenwalt, J M Hall, T W Panke, et al.
Thrombosis Research|September 15, 1982
Deficiency of a plasma factor stimulating vascular prostacyclin generation in patients with lupus nephritis and glomerular thrombi and its correction by ancrod: in-vivo and in-vitro observationsK S Kant, A K Dosekun, K G Chandran, et al.
American Journal of Nephrology|January 1, 1986
Effect of first and subsequent use of hemodialyzers on patient well-being. Analysis of the incidence of symptoms and events and description of a syndrome associated with new dialyzer useM D Robson, R Charoenpanich, K S Kant, et al.
Prostaglandins|August 1, 1986
Beneficial effects of polyunsaturated fatty acids in partially nephrectomized ratsU O Barcelli, J Miyata, Y Ito, et al.
The Quarterly Journal of Medicine|November 1, 1988
Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effectsS Kim, N K Wadhwa, K S Kant, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1985
Results of treatment in patients with end-stage renal disease: a multivariate analysis of risk factors and survival in 341 successive patientsG Garcia-Garcia, J A Deddens, R D'Achiardi-Rey, et al.
American Journal of Nephrology|January 1, 1982
Wegener's granulomatosis: prolonged patient survival after pneumonectomy and renal transplantationP K Chandran, M R First, M A Weiss, et al.
Annals of Emergency Medicine|November 1, 1988
Use of ancrod in acute or progressing ischemic cerebral infarctionC P Olinger, T G Brott, W G Barsan, et al.
Archives of Internal Medicine|January 1, 1984
Ancrod in systemic lupus erythematosus with thrombosis. Clinical and fibrinolysis effectsA K Dosekun, V E Pollak, P Glas-Greenwalt, et al.
Clinical Nephrology|August 1, 1982
Successful treatment by defibrination with ancrod in a patient with hyperacute renal allograft failure and a deficiency of plasma prostacyclin stimulating factorA K Dosekun, M R First, P K Chandran, et al.
Pageof 7